Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Cardioplegia

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Cardioplegia

Catalina Carvajal et al.
Free Books & Documents

Excerpt

Cardioplegia is a pharmacological therapy administered during cardiac surgery to intentionally and temporarily arrest the heart. The first solution used during cardiopulmonary bypass was reported by Dr. Melrose in the early 1950s, who identified that high levels of potassium citrate induced a reversible cardiac arrest. An influx of potassium depolarizes the myocardial membrane causing contraction and thus release and subsequent sequestration of calcium ions resulting in a diastolic arrest. The resting membrane potential in myocytes is about -85 mV, and with the influx of sodium ions, depolarization occurs (membrane becomes more positive -45 to -30 mV) and thus generating an action potential that is potentiated by L-type calcium channels. These voltage-gated channels are targeted with cardioplegia to induce cardiac arrest. The persistence of potassium reduces the membrane potential and does not allow for adequate repolarization. This, in turn, creating a diastolic cardiac arrest. As the solution diffuses and there is a washout of its components along with products of anaerobic cellular metabolism, electrical activity begins to appear, and redosing of cardioplegia is required if clinically indicated. Potassium, however, is not the only ion commonly found in cardioplegia. Other ions such as calcium, sodium, and magnesium all participate in reducing contractility and preserving the myocardium. Additionally, components such as lidocaine, bicarb, and even glucose may be added for further protection.

Cardioplegia is an essential component of cardiopulmonary bypass and with the primary goal to reduce myocardial oxygen demand by creating electrical quiescence and cooling the heart to reduce the ischemic effects of being on bypass. The use of cardioplegia, in addition to being cardioprotective, also provides a relatively bloodless and motionless surgical field. There are many forms of cardioplegia ranging from the location of administration retrograde vs. antegrade as well as varying components within the solution, temperature, indications, adverse effects, pharmacokinetics, and pharmacodynamics.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Catalina Carvajal declares no relevant financial relationships with ineligible companies.

Disclosure: Amandeep Goyal declares no relevant financial relationships with ineligible companies.

Disclosure: Prasanna Tadi declares no relevant financial relationships with ineligible companies.

Similar articles

References

    1. Ali JM, Miles LF, Abu-Omar Y, Galhardo C, Falter F. Global Cardioplegia Practices: Results from the Global Cardiopulmonary Bypass Survey. J Extra Corpor Technol. 2018 Jun;50(2):83-93. - PMC - PubMed
    1. Chambers DJ, Fallouh HB. Cardioplegia and cardiac surgery: pharmacological arrest and cardioprotection during global ischemia and reperfusion. Pharmacol Ther. 2010 Jul;127(1):41-52. - PubMed
    1. Matte GS, del Nido PJ. History and use of del Nido cardioplegia solution at Boston Children's Hospital. J Extra Corpor Technol. 2012 Sep;44(3):98-103. - PMC - PubMed
    1. Lopes JB, Santos CCMD. Coronary Perfusion Pressure during Antegrade Cardioplegia in On-Pump CABG Patients. Braz J Cardiovasc Surg. 2017 May-Jun;32(3):171-176. - PMC - PubMed
    1. Katayama O, Amrani M, Ledingham S, Jayakumar J, Smolenski RT, Severs N, Rothery S, Yacoub MH. Effect of cardioplegia infusion pressure on coronary artery endothelium and cardiac mechanical function. Eur J Cardiothorac Surg. 1997 Apr;11(4):751-62. - PubMed

Publication types

LinkOut - more resources